Inotek’s eye drug fails late-stage study, shares sink | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/03/inoteks-eye-drug-fails-late-stage-study-shares-sink/

(Reuters) – Inotek Pharmaceuticals Corp’s shares plunged 71 percent to a record low on Tuesday after the company said its lead experimental drug failed a late-stage study, citing a stronger-than-expected placebo effect. http://internationalnewslive.com/inoteks-eye-drug-fails-late-stage-study-shares-sink/